{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:25:27Z","timestamp":1774945527831,"version":"3.50.1"},"reference-count":30,"publisher":"BMJ","issue":"4","funder":[{"name":"SpeeDx Pty Ltd"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"accepted":{"date-parts":[[2019,8,12]]},"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>Although rapid screening and treatment programmes have been recently implemented to tackle STIs, testing<jats:italic>Mycoplasma genitalium<\/jats:italic>(MG) among asymptomatic populations is not currently recommended due to the lack of scientific evidence and the emergence of antibiotic resistance. The main objective of this study was to estimate the prevalence of MG and macrolide resistance among asymptomatic people visiting a point of care service for rapid STI screening and to identify risk factors associated with the acquisition of this infection.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Between October 2017 and January 2018, a total of 890 asymptomatic individuals attending to the STI screening service Drassanes Expr\u00e9s in Barcelona, Spain, were tested for MG and macrolide resistance using the molecular ResistancePlus MG assay (SpeeDx, Australia). Asymptomatically infected individuals were invited to attend the STI Unit for resistance-guided antimicrobial therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Overall, the prevalence of MG was 7.4% (66\/890; 95%\u2009CI 5.8% to 9.3%), being higher among men who have sex with men (MSM) (46\/489) compared with heterosexual men and women (20\/401; p=0.012). Macrolide resistance was found in 32\/46 (69.6%; 95%\u2009CI 54.2% to 82.3%) MSM, while only 2\/20 (10.0%; 95%\u2009CI 1.2% to 31.7%) infections among heterosexuals presented macrolide resistance-mediated mutations (p&lt;0.001). MSM behaviour, receptive anal intercourse, HIV positive status, syphilis history and high-risk sexual activity (more than five sexual partners in the last 3\u2009months) were significantly associated with MG infection. Furthermore, the resistance-guided therapy approach was implemented in 36\/66 (54.6%) individuals.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The research provides further data regarding the prevalence of MG and macrolide resistance among asymptomatic individuals. It also identifies higher risk subpopulations which might be targets for MG screening. Nevertheless, there is insufficient data to justify MG testing among asymptomatic individuals and current STI guidelines should be followed until evidence shows the cost and effectiveness of screening.<\/jats:p><\/jats:sec>","DOI":"10.1136\/sextrans-2019-054124","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T21:15:32Z","timestamp":1566854132000},"page":"300-305","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["Prevalence of<i>Mycoplasma genitalium<\/i>and macrolide resistance among asymptomatic people visiting a point of care service for rapid STI screening: a cross-sectional study"],"prefix":"10.1136","volume":"96","author":[{"given":"Miguel","family":"Fern\u00e1ndez-Huerta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda-Jes\u00fas","family":"Barber\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Esperalba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candela","family":"Fernandez-Naval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marti","family":"Vall-Mayans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maider","family":"Arando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4798-2385","authenticated-orcid":false,"given":"Judit","family":"Serra-Pladevall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Broto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Zarzuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariadna","family":"Rando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Pumarola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4822-1024","authenticated-orcid":false,"given":"Mateu","family":"Espasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,8,26]]},"reference":[{"key":"2024092304052144000_96.4.300.1","unstructured":"World Health Organization . Global health sector strategy on sexually transmitted infections, 2016-2017. Available: www.who.int [Accessed June 2016]."},{"key":"2024092304052144000_96.4.300.2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2015.240234"},{"key":"2024092304052144000_96.4.300.3","doi-asserted-by":"publisher","DOI":"10.1177\/0956462412472837"},{"key":"2024092304052144000_96.4.300.4","doi-asserted-by":"publisher","DOI":"10.1177\/0956462415618837"},{"key":"2024092304052144000_96.4.300.5","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/OLQ.0000000000000824","article-title":"Is screening for Chlamydia and gonorrhea in men who have sex with men associated with reduction of the prevalence of these infections? A systematic review of observational studies","volume":"45","author":"Tsoumanis","year":"2018","journal-title":"Sex Transm Dis"},{"key":"2024092304052144000_96.4.300.6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005611","article-title":"Antibiotic-resistant Neisseria gonorrhoeae spread faster with more treatment, not more sexual partners","volume":"12","author":"Fingerhuth","year":"2016","journal-title":"PLoS Pathog"},{"key":"2024092304052144000_96.4.300.7","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1473-3099(18)30080-X","article-title":"Syndromic management of STIs and the threat of untreatable Mycoplasma genitalium","volume":"18","author":"Bradshaw","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"2024092304052144000_96.4.300.8","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00006-11"},{"key":"2024092304052144000_96.4.300.9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ312"},{"key":"2024092304052144000_96.4.300.10","doi-asserted-by":"publisher","DOI":"10.1086\/599033"},{"key":"2024092304052144000_96.4.300.11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis1022"},{"key":"2024092304052144000_96.4.300.12","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/jdv.13850","article-title":"European guideline on Mycoplasma genitalium infections","volume":"2016","author":"Jensen","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024092304052144000_96.4.300.13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ644"},{"key":"2024092304052144000_96.4.300.14","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000631"},{"key":"2024092304052144000_96.4.300.15","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01053-16"},{"key":"2024092304052144000_96.4.300.16","doi-asserted-by":"publisher","DOI":"10.3201\/eid2106.142013"},{"key":"2024092304052144000_96.4.300.17","doi-asserted-by":"publisher","DOI":"10.1086\/593188"},{"key":"2024092304052144000_96.4.300.18","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2011-050035"},{"key":"2024092304052144000_96.4.300.19","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181b9d825"},{"key":"2024092304052144000_96.4.300.20","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix200"},{"key":"2024092304052144000_96.4.300.21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-16302-8","article-title":"Should we screen for the sexually-transmitted infection Mycoplasma genitalium? Evidence synthesis using a transmission-dynamic model","volume":"7","author":"Birger","year":"2017","journal-title":"Sci Rep"},{"key":"2024092304052144000_96.4.300.22","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2017-053384"},{"key":"2024092304052144000_96.4.300.23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156740","article-title":"Multiplex assay for simultaneous detection of Mycoplasma genitalium and macrolide resistance using PlexZyme and PlexPrime technology","volume":"11","author":"Tabrizi","year":"2016","journal-title":"PLoS One"},{"key":"2024092304052144000_96.4.300.24","first-page":"S65","article-title":"Antimicrobial-resistant sexually transmitted infections: gonorrhea and Mycoplasma genitalium","volume":"93","author":"Unemo","year":"2017","journal-title":"Nat Rev Urol"},{"key":"2024092304052144000_96.4.300.25","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/cid\/ciy477","article-title":"Outcomes of resistance-guided sequential treatment of Mycoplasma genitalium infections: a prospective evaluation","volume":"68","author":"Read","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2024092304052144000_96.4.300.26","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv194"},{"key":"2024092304052144000_96.4.300.27","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy025"},{"key":"2024092304052144000_96.4.300.28","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2458-14-195","article-title":"The prevalence of urethral and rectal Mycoplasma genitalium among men who have sex with men in China, a cross-sectional study","volume":"14","author":"Zheng","year":"2014","journal-title":"BMC Public Health"},{"key":"2024092304052144000_96.4.300.29","doi-asserted-by":"publisher","DOI":"10.3201\/eid2311.170998"},{"key":"2024092304052144000_96.4.300.30","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328323da3e"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2019-054124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T11:07:06Z","timestamp":1727089626000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2019-054124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,26]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,5,17]]},"published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1136\/sextrans-2019-054124"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2019-054124","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,26]]}}}